Adjuvant treatments for gastric cancer: From practice guidelines to clinical practice

Digestive and Liver Disease

Volumn 46, Issue 1, 2014, Pages 72-75

  Bouvier, Anne Marie ^a   Créhange, Gilles ^b   Azélie, Caroline ^b   Cheynel, Nicolas ^a   Jouve, Jean Louis ^a   Bedenne, Laurent ^a   Faivre, Jean ^a   Lepage, CÔme ^a   Maingon, Philippe ^b  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

Adjuvant treatment; Cancer registry; Chemoradiation; Gastric carcinoma; Radiation therapy

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER REGISTRY; CHARLSON COMORBIDITY INDEX; CLINICAL PRACTICE; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; SURGICAL MORTALITY;

ADJUVANT TREATMENT; CANCER REGISTRY; CHEMORADIATION; GASTRIC CARCINOMA; RADIATION THERAPY;

AGED; AGED, 80 AND OVER; CARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84892370406     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.07.003     Document Type: Article

References (12)

1. Jooste V., Remontet L., Colonna M., et al. Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010. European Journal of Cancer Prevention 2011, 20(5):375-380.
2. Dassen A.E., Lemmens V.E., van de Poll-Franse L.V., et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. European Journal of Cancer 2010, 46(6):1101-1110.
3. Le A., Berger D., Lau M., El-Serag H.B. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States. Annals of Surgical Oncology 2007, 14(9):2519-2527.
4. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. New England Journal of Medicine 2001, 345(10):725-730.
5. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine 2006, 355(1):11-20.
6. Sobin L., Wittekind C. TNM classification of malignant tumours 2002, John Wiley & Sons, New York. 6th ed.
7. ICD-02 International classification of diseases for oncology 1992, World Health Organisation, Geneva.
8. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987, 40(5):373-383.
9. Macdonald J., Benedetti J., Smalley S. Chemoradiation of resected gastric cancer: a 10-year follow-up of the phase III trial INT0116 (SWOG 9008). Journal of Clinical Oncology 2009, 27(suppl(205s)). abstr 4515.
10. Strauss J., Hershman D.L., Buono D., et al. Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival. International Journal of Radiation Oncology, Biology, Physics 2010, 76(5):1404-1412.
11. Dikken J.L., Jansen E.P., Cats A., et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. Journal of Clinical Oncology 2010, 28(14):2430-2436.
12. Ychou M., Boige V., Pignon J.P., et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. Journal of Clinical Oncology 2011, 29(13):1715-1721.